These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 18078395

  • 1. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P.
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA, Turner ML.
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG, Drohan W.
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML, Ludlam CA.
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [Abstract] [Full Text] [Related]

  • 9. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T, Padilla A.
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Creutzfeldt-Jakob disease and the risk from blood or blood products.
    Will RG, Kimberlin RH.
    Vox Sang; 1998 Nov; 75(3):178-80. PubMed ID: 9852403
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of prion disease transmission].
    Kishida H, Kuroiwa Y.
    Nihon Rinsho; 2007 Aug; 65(8):1454-9. PubMed ID: 17695283
    [Abstract] [Full Text] [Related]

  • 13. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
    Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M.
    Neuropathology; 2009 Oct; 29(5):625-31. PubMed ID: 19659942
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Iatrogenic prion diseases in humans: an update.
    Barrenetxea G.
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):165-9. PubMed ID: 22951159
    [Abstract] [Full Text] [Related]

  • 20. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
    Sutton JM, Dickinson J, Walker JT, Raven ND.
    Clin Infect Dis; 2006 Sep 15; 43(6):757-64. PubMed ID: 16912952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.